Bio-Rad Laboratories | BIO - 当期純利益





当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
Agilent USD 305M 129M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bio Techne USD 38.01M 176K 2025-12
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Bruker USD 26M 88.4M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Danaher USD 1.03B 168M 2026-03
General Electric Aerospace USD 1.9B 637M 2026-03
Illumina USD 334M 184M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Merck USD 2.96B 2.82B 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 251M 6M 2026-03
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Siemens EUR 2.03B 411M 2025-12
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Tosoh JPY 17.25B 16.4B 2025-12
Waters USD 225.21M 76.29M 2025-12